InsiderTrades

Form 4 for VERX Vertex, Inc.

Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-15 · accession 0001415889-23-016732 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-12-19 2023-12-15 VERX Rowland Bryan T.R. GC M - OptEx $3.17 +62.4K 66.8K +1,429% +$197.9K
DM 2023-12-19 2023-12-15 VERX Rowland Bryan T.R. GC S - Sale+OE $26.95 -66.8K 0 -100% -$1.80M
D 2023-12-19 2023-12-15 VERX Rowland Bryan T.R. GC M - OptEx $0.00 -62.4K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-12-15 M A 62,433 $3.17 66,802 D — — (F1) Includes 458 shares acquired through the Company's Employee Stock Purchase Plan.
2 Common Class A Common Stock 2023-12-15 S D 62,433 $26.96 4,369 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.66 to $27.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
3 Common Class A Common Stock 2023-12-15 S D 4,369 $26.86 0 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.68 to $27.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
4 Derivative Stock Option 2023-12-15 M D 62,433 $0.00 0 D $3.17 · — to 2028-02-09 62,433 Class A Common Stock (F4) This option became exercisable as to 50% of the shares on the date of grant and with respect to the remaining shares on February 9, 2023.